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The complete cDNA structure of the Ap1y.w californm pro-protein and pro-hormone convertase PC2 (aPC2) was obtained from a cDNA library 
of the nervous system. The deduced amino acid sequence revealed that aPC2 exhibits an 85%, 61% and 62% sequence identity to the L~~naea 
stagnalis, Xenopus laevis and mouse PC2 homologues, respectively. The deduced primary sequence suggested a protein of 653 ammo acids which 
includes a 27- and 88-amino acid signal peptide and pro-segment. The signal peptide and the C-termmal segments are the least conserved regions. 
On Northern blots of nervous system we detected a transcript of 6.8 kb. The m situ hybridization histochermstry on the abdominal ganglion revealed 
intense labeling of the bag cells. Large peptidergic cells and clusters of sensory and motor neurons also contained high levels of aPC2 mRNA. 
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1. INTRODUCTION 
Peptides and neuropeptides are usually synthesized in 
the form of precursors which must undergo proteolytic 
cleavage at selected single or pairs of basic residues. in 
order to release the bioactive moiety [l]. Six enzymes 
belonging to a new family of subtilisin-like proteinases, 
known as convertases, have been recently characterized 
at the molecular level. These include furin [2], PC1 [3], 
PC2 [4,5], PACE4 [6]. PC4 [7.8] and PC5 [9]. Further- 
more, some of them have been shown to cleave pro- 
protein and pro-hormone precursors specifically at the 
pairs of basic residues known to be cleaved in vivo (for 
reviews see [lO,l 11). While furin and PACE4 have a 
rather ubiquitous distribution, PC5 has a more re- 
stricted one [9]. PC4 is exclusively expressed in testicular 
germ cells and ovaries [7,8]. On the other hand, PC1 and 
PC2 are mostly expressed within neural and endocrine 
cells of mammals [3-5,121. 
Many neuropeptides of the marine mollusc Aplysia 
californica exist in the form of precursors that must be 
processed in order to become active. The pro-egg laying 
hormone (pro-ELH) represents one such extensively 
studied precursor. It undergoes a series of nine cleav- 
ages at specific tetra-, tri- and di-basic sites to produce 
ELH and various bag cell peptides [13]. Other regions 
of the abdominal ganglion contain precursors also 
known to be cleaved at pairs of basic residues [14]. It 
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therefore seemed likely that the nzymes responsible for 
the processing of Aplysiu precursors would belong to 
the same family of subtilisin-like serine proteases. This 
paper describes the molecular cloning of an Aplvsiu 
PC2-like convertase and the study of its distribution in 
identified neurons of the abdominal ganglion by in situ 
hybridization. 
2. MATERIALS AND METHODS 
2.1. Animuls 
Adult Aplysiu culijbrmcu (15&250 g) were purchased from Marine 
Specimen Unlimited (CA, USA) and kept under standard laboratory 
conditions (hght-dark cycle: 12 h; fed with dry seaweed every other 
day: water temperature 14’C; pH 7.8-8.2). 
2.2. PCR. Ithrary screenrng und DNA sequencing 
Polymerase chain reactions were performed in a Perkin-Elmer/ 
Cetus DNA cycler using degenerate ohgonucleotldes located m the 
highly conserved catalytic region. The sequences of the sense (OLl) 
and antlsense (OL2) oligos are as follows: 
OLI, 5’-TCGATATCTACAG(T/C)GC(A/C)AG(C/A)TGGGGCCC-3’: 
OL?, 5’-TAGGATCGAG(A/G,TG(CK)TGCATGTC(T/C)C(T/G)CC- 
AGGT-3’ [8,9]. 
Purified DNA from a cDNA library of the nervous system of Aply- 
.~a (lambda ZAPII. kindly provided by Dr. D. Solomon, Columbia 
U., N.Y.) was subjected to 30 cycles of amplification (1 min. 94°C; 2 
mm, 55°C; 3 min. 72°C). The expected 450bp band was subcloned 
(TA-Clomng Kit. Invitrogen, San Diego, CA), and sequenced. The 
PCR product was used as a probe to screen approximately 1 million 
clones of the cDNA hbrary accordmg to a modified method from [15]. 
Positive clones were purllied by a second round of hybridization. 
DNA sequence analysis was performed automatically using an ALF 
DNA sequenator (Pharmacia) usmg 5’-end labeled fluorescent ol- 
igonucleotides as primers for the sequence analysis. 
2.3. Northern blots und m situ hybrldizatlon 
Ap/y.va nervous system total RNA preparation. and Northern blot 
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analysis were carried out as previously described in [16]. The filter was stereomicroscope and freshly fixed m 4% parafo~aldehyde. The par- 
hybridized to an antisense cRNA probe to aPC2. affin-embedded 5-pm thick sections were hybridtzed with a “S-labeled 
For in situ hybridization, single gangha were dissected under a cRNA probe to aPC2 usmg a modrfied method described in [17]. 
AGCTAWLGCAGRGCTAcTGCCCGCCTTWLCGCGCTGGGGG CGT~~T~ThC~TA~TTTTA~~C~ G~CTCCCCCTTT~GT~C~G~TT~ 
AGABAC~GAGGCA TULGCGTGTTAGAGGGACTGTTCTACGT~~CTT~G~~TTTTGTTTTGT~TCGCGTGTTTT~T~TCGTTCG~TTCT~CCCGT~ 
TCGTRARTTCTGGGTTTATCTACAC;GCTCAACGTACGC~TT~CTACCGTT~TCTAGTTGTGTGTTCGT~~TTGCGT~CG~~TAGT~GT~G~GT~TGTT~T 
GCTCTCTCARAGTA~CTCCTCAAACCTCGTTTCATCAAAGAG 
GCTGAWLGGARRAGCTGCTGCCTT~GTGCTAT 
-27 -20 -10 clrL 
HetserIlePhePheserGlyTrpProHisLysValLeuLeuProLeuCysLeuLeuPheT~pAlaProTrPValP~oG~Y~~sGlYA~~~~~Il~sPV~~ 
GGACTCTTCG~TATTATGAGTATTTTCTTCTCTG~TGGCCTCAT~GGTGTTGCTGCCGCTATGCCTGTTGTTCTGGGCTCCCTGGGTG~~TG~~A~GG~~~CA~TAGATGTG 
10 20 30 40 
ValThrAsnH~sTrpLeuValGluLeuSerH~sAspG1yGlyProGluLeuAlaLy~gValAlaArgAspThrGlyPheSerT~~VslGlYP~~V~l~s~Se~Ss~~~~4T~~P~~ 
GT~CTRAcCACTGGTTGGTGGTTAGCCATGRCGGGGGACCT~CTGGCT~~GGGTAGCCC~CGAChCAGGCTTCAGCTATGTAG~CcGGTA~T~TcATc~CcG~cGTTC 
50 60 70 80 
H1sPheValHisH~sGlyValAlaHisAl~s~r~~~servslFroH~sThrArgGlnL@~rgValHlsProHisValValSerAlaPheGlnGl~snGlYTyrSe~~ 
W\TTTTGTACATU\TGGCGTAGCGCATGCACGTTC~G~~GTGTACCTCACAC~GAC~CT~GGGTGCATCCT~CGTTGTTTCAGccTTcC~CAG~TGGcTAcTC~GGGTG 
i SO 100 110 120 
LyrAtpGlyTyrLysGlnThrAspLysLeuLeuGl~laAsnLysGlnSerPheAlaTyrLysAlaLysPrOArgLeuProAs~SPP~oAspPheG~YLYsGl~T~PTY~Le~~~As~ 
AARCGTGGGTACAAACAGACTGACARGTTACTAC~GC~C~C~GTTTTGCCTAC~GCC~CC~GACTTCCC~T~CCCGGATTTCGG~~AGTGGTACTTGAG~~ 
130 140 150 
8 w 
ThrGlyGluSerGlyGlyValLysGlyLeuAspLe~snValLeuGl~laTrpGl~etGlyTyrSerGlyAlaGlyValThrThrAlaIleMe~tappSpGlYIl~AsPTY~Le~~~s 
ACTGGCGRGTCCGWLGGCGTGAAAGGCCTAGATCTC~TGTGCTG~GCTT~~GATGGGCTACTCTGG~GCCGGCGTCACGACAGCCATTATGGAC~TGGTATTGACTATCTACA~ 
170 180 190 200 . 
GluAspLeuLysPheAsnTyrH~sAlaAspAlaSerTyrAspPheSerSerAs~spProTyrProTyrProArgTyrThrAspTh~TrpPheASnSe~HlsGlYTh~A~gCysAl~GlY - 
GRGGACCTCAAGTTTAATTACCACGCGCGGACGCCAGCTACGATTTCAGCAGC~CGACCCCTACCCATACC~CGATACACA~CACATGGTTC~CAGCCACGGCACCCGATGTG~GGGC 
210 220 230 240 
GluValSerAlaAlaLysAspAsnG1yValCysGlyValGiyValAlaPheGlySerLysValAlaGlyLe~rgMetLe~spGlnProPheMetThrAspLeuXleGluAlaAsnAl~ 
GAGGTGTCGGCAGCAAAGGACAACGGTGTGTGCG~GTG~CGTGGCTTTTGGTTCC~GTGGCAGGTCTGAG~TGCTCGACC~CCGTTCATGACCGACCT~TCGAGGCT~CGCA 
250 260 270 280 
MetGlyH~sMetP~OAsnVa1IleAs~IleTyrSerAlaSerTrpGlyProThrAspAspGly~ysTh~V~lAsp~lyP~~A~g~Le"Th~~e~A~~~l~~leV~lAs~GlyV~lAs~ 
ATGGGCCACATGCCU\ATGTCATCTACAGCGCCTCTACAGCGCCTCCTGGGGGCCCACG~C~CGGC~GACAGTGGACGGGCCCCGG~CCTCACCAT~G~GCGATCGTC~CGGTGTC~T 
290 300 
0 
310 320 
AsnGlyArgAsnGlyLeuGly~nValTyrValTrpAlaSerGly~~lyGlyProAsnAspAspCysAsnCysAspGLyTyrAlaAlaSer~etTrpThrValSerIleAsnSerAla 
AACGGTCGTAACGGACTTGGGAACGTCTACGTTTGGGCGTTTGGGCGTCAGGTGACGGAGGACCT~CGAC~CTGC~CTGTGATGGCTACGCCGCCAGCATGTGGACTGTCAGCATC~CTCGGCC 
330 340 350 360 
ThrAsnAspGlyG1nThrAlaGlyTyrAspGluSerCysSerSerThrLeuAlaSerThrPheSerAsnGlyLysSerSerSerArgAspAlaGlyValAlaThrThrASpLeuTyrAsn 
ACUV\CGACGGACRGACCGCTGGCTACGACGAGTCCTGCTGCTCCTCCACCCTCGCTTCTACCTTCAGC~CGGC~GCAGCTCTCGGGACGCCGGTGTGGCCAC~CAGACCTATAC~C 
370 
I 
380 390 400 
~;lCysThrAlaSerH~sSerGlyTh~~~~Al~l~l~P~~Gl~lsA~~GlyVslPheA~~Le~l~Le~G~~lsAs~Lys~L~~Th~T~pA~~Asp~etGl~~~s~~~Th~Vsl - 
AACTGCACCGCCAGTCACTCTGGGACTTCCGCCGCCGCCCCT~GGCAGCCG~GTGTTCGCCCTTGCTCTG~GGCC~C~CCTCACCTGGCGT~CATGC~~CTTGACAGTA 
410 420 430 440 
LeuThrSerLysAylASnSerLeuTyrAsPSe~~nGlyIleHlsH~sTrpLysLeuAsnGlyAlaH~sLeuLeuPheAsnH~sLeuPheGlyTyrGlyValLe~spAl~l~Se~~et 
CTUlCCTCCAAGAGAARTTCCCTGTATGATTCT~CGG~TCCACCACTGGAAGCTGAACGGCGCTCACCTCCTGTTCAACCATTTGTTTGGCTATGGAGTTTTGGACGCTGCCAGCATG 
450 460 470 480 
Val~PLe~l~~~Gl~T~PLYsGlY~~~P~OGl~r~PheHlsCysLysAlsGlySerIleThrAspLysGlnAspPheSerPheGlyAsnProValArgMetSerIleGluThrAsp 
GTGWITCTGGc~~~GTGWIRGGUCfTGc~~GGTTCCACTG~GG~GGCAG~T~CTGAC~G~GACTTCTCCTTCGGC~CCCCGTACG~T~GChTC~CT~C 
490 500 510 520 
G~YCYSVslGlYTh~~l~s~Gl~Vs~AS~TY~LeUGlUHlsValGl~laPheValThrLe~rgSerThrTyrArgGlyCysValThrMetTyrLeuThrSe~P~oM~tGlyTh~Th~ 
GGCTGTGTGGG~ACAGAGAATGAGGTCAACTATCTATCTGGAGCACGTTCAGGCGTTTGTCACCCT~GGTCCACCTACCGCGGTTGTGT~C~TGTACCT~~TTCG~~~TGGG~~~~ 
530 540 550 560 
S~~~~~I~~L~~S~fGl~~9P~~As~sPAsPAsP~FLysRsnGlyPheT~rArgTrpProPheMe~ThrThrH~sThrTrpAlaGluLeuSerH~sGlyThrTrpSerLe~Gl~Ii~ 
TC~TGATT~T~AG~~~~G~~~T~T~~~~~CGAC~CG~TT~CCCGCTGGCCTTTCAT~CCACCCACACCTGGGCCGAGCTCTCCCACG~CCTGGTCCCTG~~TC 
570 580 590 600 
Vs~~~~Gl~P~~~l~I~~GlYVslLY~T~~As~etGlUArgGlyValPheLysGluTrpThrLeuValLeuH~sGlyThrLysThrProProTyrAl~snGl~P~oAl~spLysAsp 
GTCATG~GC~~TC~TCG~~GT~~~~~~~ATGGAGA~GGGGTCTT~G~GTG~CGTTGGTGCTG~TGG~~GA~CCGCCCTACGC~TCAG~~G~C~~~~ 
610 620 626 
LySGl~GlULYsL~~Ty~LeUVslP~oProCysProArgGluCysVslIl~A~pGl~ 
~C~~G~TATA~~TTGTT~~~~CGT~~~~~~GAGTGCGTCATC~T~GT~CTCCT~TCT~CTGC~GGC~TG~G~~~GTGGCT~CTTCC~TTT~CTG 
TGAGCCGTGCGCCATCTTGT~CTTGCTACTCCTC~~CCCTCGCTCGTA~CGT~TGGCGT~~TTATTTT~GTG~TGTTA~CTGTTTCT 
120 
240 
360 
480 
600 
720 
960 
1080 
I.200 
1320 
1440 
1560 
1680 
la00 
1920 
a040 
2160 
2280 
2400 
2520 
2640 
2739 
Fig. 1. Complete cDNA and the deduced amino acid sequence of aPC2. The active site AX(W) W&(H). and SG(W), and the important As(o) 
residue, as well as the three potential N-glycosylatton (44) sttes and the position of the sulfated Tyr ((++) sequence [19] are emphasized. The 
predtcted sites of the signal peptidase cleavage and zymogen activation are depicted by dtfferent arrows, respectively. The 4 pairs of basic restdues 
are m bold 
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3. RESULTS AND DISCUSSION 
One purpose of this study was to isolate and charac- 
terize the cDNA structures of pro-hormone convertases 
in the nervous system of Aplysia. We thus started by 
generating a specific probe by PCR, which we subse- 
quently used to screen a cDNA library. After the second 
round of screening, we obtained 20 positive clones. Two 
clones (#S-PC, #9-PC), containing inserts of 5 kb and 
2.3 kb, respectively, were completely sequenced. While 
both clones contained identical sequences, only the 
longest of the two (M-PC) gave us a full-length struc- 
ture. 
The cDNA sequence of the first 2739 bp of this 5 kb 
clone showed an open reading frame starting from nt. 
619 up to 2577, coding for a protein containing 653 
amino acids. This suggested the presence of a 618 nt- 
long 5’-untranslated region, which is unusually long and 
could be important in the regulation of aPC2 mRNA 
levels. The 3’ end of this clone was not fully sequenced 
as it represents a non-coding segment of the cDNA. The 
analysis of the sequence suggested the presence of a 
signal peptide of 27 amino acids (Fig. l), the cleavage 
of which would result in a 626 amino acids-long pro- 
teinase. Comparison of this sequence and the deduced 
amino acid structure to those of the known convertases, 
suggested that this is an Aplysia PCZlike sequence 
(aPC2), as it resembles best this convertase in its struc- 
ture. Thus, although it contains the Asp-160, His-201 
and Ser-377 residues found in the catalytic triad of the 
serine proteinases of the subtilisin-type, it characteristi- 
cally contains an Asp-303 in place of the usual catalyti- 
cally important Asn found in subtilisins and in all the 
other convertases except for PC2 [4,5,10,11]. The calcu- 
lated overall identity of sequence are 85%, 61% and 62% 
at the protein level and 73%, 58% and 58% at the nucle- 
otide level with the sequences of Lymnaea stagnalis (ly) 
[18], Xenapus lads (xen) [19] and mouse PC2 [4], re- 
spectively, with the catalytic segment (residues 90493) 
being the most conserved and the N- and C-terminal 
sequences showing considerable variations. 
Recently, we have shown that PC1 and PC2 are first 
synthesized as precursor enzymes (zymogens) which un- 
dergo post-translational modifications leading to the 
excision of their N-terminal pro-segment via the cleav- 
Kb 
7.5 - 
4.4 - 
2.4 - 
Fig. 2. Northern blot: total nervous system RNA (5 pg) hybridized to 
aPC2. The transcript is estimated at 6.8 kb. 
Ftg. 3. Localisation of aPC2 mRNA in the bag cells cluster (A) and 
the large peptidergic neurons (R3-R14) of the right upper quadrant 
region of the abdominal ganglion (B). Control adjacent section of the 
bag cells cluster was hybridized to the sense probe (C). Another adja- 
cent section was pretreated with RNAse and subsequently exposed 
to the antisense probe (D). The calibration mark for all sections is 
100 PM. 
age at a specific LysArg sequence [20,21]. Therefore, we 
expect that aPC2 would, like mammalian PC2s, be syn- 
thesized first as a zymogen with an 89-amino acid pro- 
segment which would then be cleaved, possibly within 
the trans-Golgi network [21] at the ArgValLysArg-891 
sequence, to release the active enzyme. As shown in Fig. 
1, the mature enzyme would therefore contain 537 
amino acids, three potential Asn-glycosylation sites and 
one potential Tyr sulfation site which is conserved in all 
PC2 structures [21]. Similar to lyPC2 [18], but different 
from xenPC2 [19]. we notice in aPC2 the absence of the 
characteristic ArgGlyAsp (RGD) sequence found in all 
mammalian convertases. The equivalent sequence in 
aPC2 is ArgGlyCys (residues 513-516). It is interesting 
to note that the C-terminal sequence of aPC2 is quite 
different from any PC2-like structure known and that 
it contains two extra Cys residues and is not predicted 
to contain an amphipathic a-helix, as was suggested for 
mammalian PC2s [4.5,22]. We also noticed that aside 
from those present within the pro-segment of aPC2 (res- 
idues 28-89), only one pair of basic residues is found in 
the catalytic region of the aPC2 structure. This is in 
contrast to mammalian PC2s which contain a number 
of pairs of basic residues within both the catalytic and 
C-terminal segments of the molecule [3,5,22]. 
Northern blot analysis revealed a single transcript of 
6.8 kb in the nervous system (Fig. 2). In situ hybridiza- 
tion revealed the presence of aPC2 mRNA in the major- 
ity of neurons of the abdominal ganglion, where we 
focussed our attention. The reconstruction of the serial 
sections enabled us to identify specifically labelled cells. 
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The bag cells as well as large peptidergic neurons like 
the L2-L6 and R3-R14 [23,24] were among the highly 
responsive cells (Fig. 3). We also observed that regions 
containing the sensory clusters, interneurons and motor 
neurons of the gill and siphon withdrawal reflex con- 
tained many labelled cells [25]. The labelling of the neu- 
rons was not uniform and several cells were unrespon- 
sive; thus, the giant cell R2 does not seem to contain any 
aPC2 mRNA. While the presence of aPC2 mRNA is not 
surprising in the neurosecretory bag cells [13,26] or 
large peptidergic neurons, it is interesting to find a PC2 
mRNA in the neurons mediating the gill and siphon 
withdrawal reflex which undergoes short and long-term 
behavioral modifications [27]. While these cells are 
known to contain classical neurotransmitters, the pres- 
ence of aPC2 mRNA could suggest the presence of 
peptide precursors in these neurons. This would tend to 
confirm the generality of cotransmission [38] and sug- 
gest a physiological role of the convertases in the mod- 
ulation of behavior. The possibility of using large iden- 
tified neurons in the central nervous system of Apll.sicr 
will allow us to test the specific conditions under which 
the convertase activity could be amplified or attenuated. 
Moreover, the presence of aPC2 mRNA in identified 
cells could enable us to find potential substrates to this 
pro-hormone convertase. The identification of the other 
members of the family of convertases should allow us 
to examine the differential role of each convertase in the 
cellular and molecular basis of learning and memory. 
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